Provided By PR Newswire
Last update: Jan 8, 2025
NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neurogene Inc. ("Neurogene" or the "Company") (NASDAQ: NGNE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:NGNE (7/18/2025, 3:37:42 PM)
22.47
-0.13 (-0.58%)
Find more stocks in the Stock Screener